BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16442192)

  • 1. The gray platelet syndrome: clinical spectrum of the disease.
    Nurden AT; Nurden P
    Blood Rev; 2007 Jan; 21(1):21-36. PubMed ID: 16442192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors.
    Breton-Gorius J; Vainchenker W; Nurden A; Levy-Toledano S; Caen J
    Am J Pathol; 1981 Jan; 102(1):10-9. PubMed ID: 7468753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megakaryocytes and myelofibrosis in gray platelet syndrome.
    Caen JP; Deschamps JF; Bodevin E; Bryckaert MC; Dupuy E; Wasteson A
    Nouv Rev Fr Hematol (1978); 1987; 29(2):109-14. PubMed ID: 3615193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics.
    Falik-Zaccai TC; Anikster Y; Rivera CE; Horne MK; Schliamser L; Phornphutkul C; Attias D; Hyman T; White JG; Gahl WA
    Mol Genet Metab; 2001 Nov; 74(3):303-13. PubMed ID: 11708859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gray platelet syndrome, an example of myelofibrosis of megakaryocytic origin].
    Caen JP; Cramer EM; Rendu F; Bryckaert M; Dupuy E; Levy-Toledano S
    Bull Acad Natl Med; 1991 Oct; 175(7):1145-52; discussion 1152-3. PubMed ID: 1809489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital disorders associated with platelet dysfunctions.
    Nurden P; Nurden AT
    Thromb Haemost; 2008 Feb; 99(2):253-63. PubMed ID: 18278172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome.
    Larocca LM; Heller PG; Podda G; Pujol-Moix N; Glembotsky AC; Pecci A; Alberelli MA; Balduini CL; Landolfi R; Cattaneo M; De Candia E
    Platelets; 2015; 26(8):751-7. PubMed ID: 25806575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gray platelet syndrome].
    Lutz P; Roth-Pougheon A; Wiesel ML; Albert A; Brisson C; Grunebaum L; Cazenave JP; Lévy JM
    Arch Fr Pediatr; 1992; 49(7):637-40. PubMed ID: 1476482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphotyrosine proteins in platelets from patients with storage pool disease: direct relation between granule defects and defective signal transduction.
    Arderiu G; Díaz-Ricart M; Domenech P; Escolar G; Ordinas A; Pujol-Moix N
    Haematologica; 2002 Jun; 87(6):629-36. PubMed ID: 12031920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inherited macrothrombocytopenic disorder with abnormal large granules.
    Wu S; Wang Z; Dai L; Huang R; Wang X; Li S; Bai X; Mao D; Ruan C
    Platelets; 2006 Jun; 17(4):259-65. PubMed ID: 16769603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-delta platelet storage pool deficiency in three generations.
    White JG; Keel S; Reyes M; Burris SM
    Platelets; 2007 Feb; 18(1):1-10. PubMed ID: 17365847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
    Petrides PE; Siegel F
    Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia I ultrastructure.
    White JG; Nichols WL; Steensma DP
    Platelets; 2007 Jun; 18(4):273-83. PubMed ID: 17538848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serglycin proteoglycan size is associated with the platelet alpha granule storage defect in Wistar Furth hereditary macrothrombocytopenic rats. Serglycin binding affinity to type I collagen is unaltered.
    Schick BP; Pestina TI; San Antonio JD; Stenberg PE; Jackson CW
    J Cell Physiol; 1997 Jul; 172(1):87-93. PubMed ID: 9207929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dominant-negative GFI1B mutation in the gray platelet syndrome.
    Monteferrario D; Bolar NA; Marneth AE; Hebeda KM; Bergevoet SM; Veenstra H; Laros-van Gorkom BA; MacKenzie MA; Khandanpour C; Botezatu L; Fransen E; Van Camp G; Duijnhouwer AL; Salemink S; Willemsen B; Huls G; Preijers F; Van Heerde W; Jansen JH; Kempers MJ; Loeys BL; Van Laer L; Van der Reijden BA
    N Engl J Med; 2014 Jan; 370(3):245-53. PubMed ID: 24325358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of infusing rat monoclonal antibodies to the murine GPIb-IX-V complex on platelet and megakaryocyte morphology in mice.
    Poujol C; Bergmeier W; Nurden P; Nieswandt B; Nurden A
    Platelets; 2003 Feb; 14(1):35-45. PubMed ID: 12623445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant electron-dense chains, clusters and granules in megakaryocytes and platelets with normal dense bodies: an inherited thrombocytopenic disorder.
    White JG
    Platelets; 2003 Mar; 14(2):109-21. PubMed ID: 12745453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic changes in the megakaryocyte-platelet lineage.
    Stenberg PE
    Scanning Microsc; 1988 Dec; 2(4):2117-27. PubMed ID: 3238385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients.
    Di Buduo CA; Alberelli MA; Glembostky AC; Podda G; Lev PR; Cattaneo M; Landolfi R; Heller PG; Balduini A; De Candia E
    Sci Rep; 2016 Mar; 6():23213. PubMed ID: 26987485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medich giant platelet disorder: a unique alpha granule deficiency I. Structural abnormalities.
    White JG
    Platelets; 2004 Sep; 15(6):345-53. PubMed ID: 15370096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.